Skip to main content
Fig. 7 | BMC Medical Genomics

Fig. 7

From: Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer

Fig. 7

The DEGs between groups and potential drug targets for high-risk group. A GO and KEGG analyses of DEGs from high-risk group compared with low-risk group; B ridge map of gene set enrichment analysis (GSEA) for DEGs from high-risk group compared with low-risk group; C Connectivity Map (CMap) analysis to find the potential drug targets for high-risk group. The 20 top and bottom drugs represented positive and negative correlations, respectively, with BRCA patients in high-risk group. CMap analysis identified terconazole, QX-314, and several histamine receptor modulators as potential therapeutic drugs for BRCA patients in high-risk group

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us